IDYA

NASDAQ · Biotechnology

Ideaya Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$30.78

-1.58 (-4.88%)

As of Nov 5, 8:40 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +282.3% upside

Low Target $81.99

Average Target $117.67

High Target $158.58

Current Price $30.78

Current
$30.78

Target
$117.67

$81.99 $117.67 avg $158.58

Scenario Analysis

Bear Case

$81.99

166.4%

Low target

Base Case

$117.67

+282.3%

Avg target

Bull Case

$158.58

+415.2%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$42.68

-27.9% from high

52-Week Low

$26.81

+14.8% from low

50-Day SMA

$36.71

-16.2% vs SMA

200-Day SMA

$33.96

-9.4% vs SMA

RSI (14)

43.9

Neutral

Target vs 52W High

$117.67

+175.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%